lobbying_filings_raw: 7faec0a4-7ff2-4c47-bfc5-e71ea29c93c2

Raw lobbying disclosure filings from the Senate Office of Public Records (SOPR). Each row is a single filing — registrations, quarterly reports, amendments, and terminations. Includes registrant and client names, reported income/expenses, filing period, and the full raw JSON from the API.

This data as json

filing_uuid filing_type registrant_id registrant_name client_id client_name filing_year filing_period received_date amount_reported is_amendment is_no_activity is_termination raw_json
7faec0a4-7ff2-4c47-bfc5-e71ea29c93c2 Q1 401104300 MICHAEL N. MCCARTY LAW OFFICE PLLC 201345 AMERICAN MEDICAL TECHNOLOGISTS 2021 first_quarter 2021-04-15T14:17:26.553000-04:00 10000.0 0 0 0 {"url": "https://lda.senate.gov/api/v1/filings/7faec0a4-7ff2-4c47-bfc5-e71ea29c93c2/", "filing_uuid": "7faec0a4-7ff2-4c47-bfc5-e71ea29c93c2", "filing_type": "Q1", "filing_type_display": "1st Quarter - Report", "filing_year": 2021, "filing_period": "first_quarter", "filing_period_display": "1st Quarter (Jan 1 - Mar 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/7faec0a4-7ff2-4c47-bfc5-e71ea29c93c2/print/", "filing_document_content_type": "text/html", "income": "10000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Michael N. McCarty", "dt_posted": "2021-04-15T14:17:26.553000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "1050 30th Street NW", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20007", "registrant": {"id": 401104300, "url": "https://lda.senate.gov/api/v1/registrants/401104300/", "house_registrant_id": null, "name": "MICHAEL N. MCCARTY LAW OFFICE PLLC", "description": "Law Firm", "address_1": "1050 30th Street NW", "address_2": null, "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20007", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "MICHAEL N. MCCARTY", "contact_telephone": "+1 202-243-7842", "dt_updated": "2026-01-20T15:43:31.313792-05:00"}, "client": {"id": 201345, "url": "https://lda.senate.gov/api/v1/clients/201345/", "client_id": 12, "name": "AMERICAN MEDICAL TECHNOLOGISTS", "general_description": "Certification organization and professional society for allied health personnel", "client_government_entity": false, "client_self_select": null, "state": "IL", "state_display": "Illinois", "country": "US", "country_display": "United States of America", "ppb_state": "IL", "ppb_state_display": "Illinois", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2017-01-02"}, "lobbying_activities": [{"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "Legislation affecting payment for clinical laboratory diagnostic tests, including but not limited to COVID-19 tests.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 66055, "prefix": null, "prefix_display": null, "first_name": "MICHAEL", "nickname": null, "middle_name": "N", "last_name": "MCCARTY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}, {"id": 12, "name": "White House Office"}]}, {"general_issue_code": "MED", "general_issue_code_display": "Medical/Disease Research/Clinical Labs", "description": "Support S. 236, the Tracking COVID-19 Variants Act; support funding for the Centers for Disease Control & Prevention (CDC) Advanced Molecular Detection (AMD) program; support funding for CDC's Environmental Health Laboratory to (1) generate pediatric reference intervals for clinical diagnostic testing on children and (2) harmonize clinical laboratory test results across different testing platforms; monitor legislative efforts to regulated laboratory-developed tests (LDTs); support initiatives to improve COVID-19 testing supply chains.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 66055, "prefix": null, "prefix_display": null, "first_name": "MICHAEL", "nickname": null, "middle_name": "N", "last_name": "MCCARTY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}, {"id": 12, "name": "White House Office"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []}

Links from other tables